What is the recommended treatment for syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Syphilis

Benzathine penicillin G is the preferred treatment for all stages of syphilis, with dosing and duration determined by the stage of infection. 1, 2

Primary and Secondary Syphilis

Administer benzathine penicillin G 2.4 million units intramuscularly as a single dose. 1, 2, 3

  • This single injection is highly effective for early-stage disease and remains the gold standard treatment 1
  • Expect a fourfold decline in nontreponemal titers within 6 months 1, 2
  • For children with acquired primary or secondary syphilis, dose is 50,000 units/kg IM (up to adult dose of 2.4 million units) 1

Early Latent Syphilis

Use the same regimen as primary/secondary syphilis: benzathine penicillin G 2.4 million units IM as a single dose. 1, 2

  • Early latent is defined as infection acquired within the preceding year, documented by seroconversion, fourfold titer increase, recent symptoms, or partner with documented early syphilis 2

Late Latent Syphilis and Latent Syphilis of Unknown Duration

Administer benzathine penicillin G 7.2 million units total, given as three doses of 2.4 million units IM at weekly intervals. 1, 2

  • This extended regimen is necessary due to longer infection duration 1
  • Expect a fourfold decline in titers within 12-24 months 1, 2
  • If a dose is missed, an interval of 10-14 days between doses may be acceptable before restarting the sequence, though 7-9 days is more optimal 4
  • Missed doses are NOT acceptable for pregnant women 4

Tertiary Syphilis

Before treating tertiary syphilis, perform CSF examination to exclude neurosyphilis. 5

  • If neurosyphilis is ruled out, treat with benzathine penicillin G 7.2 million units total (three weekly doses of 2.4 million units IM) 5
  • If neurosyphilis is present, the treatment changes entirely to aqueous crystalline penicillin G 18-24 million units IV daily for 10-14 days 2, 5
  • The tertiary syphilis regimen is inadequate for CNS involvement 5
  • Some specialists treat all cardiovascular syphilis cases with neurosyphilis regimens due to concern for CNS involvement 5

Neurosyphilis

Administer aqueous crystalline penicillin G 18-24 million units per day IV (given as 3-4 million units every 4 hours or continuous infusion) for 10-14 days. 2

  • An alternative is procaine penicillin G with probenecid, though procaine penicillin without probenecid does not achieve adequate CSF levels 2
  • CSF examination is indicated for patients with neurologic/ophthalmic symptoms, tertiary syphilis, treatment failure, HIV with late latent syphilis, or nontreponemal titer ≥1:32 2

Penicillin-Allergic Patients (Non-Pregnant)

For primary, secondary, or early latent syphilis: doxycycline 100 mg orally twice daily for 14 days. 1, 2

For late latent syphilis or latent syphilis of unknown duration: doxycycline 100 mg orally twice daily for 28 days. 1, 2

  • Tetracycline 500 mg orally four times daily is an alternative (14 days for early, 28 days for late) 2
  • Ceftriaxone 1 gram IM/IV daily for 10-14 days may be considered based on randomized trial data showing comparable efficacy to benzathine penicillin 2, 4
  • However, ceftriaxone has limited data for late latent and tertiary syphilis, and patients with severe penicillin allergy may also react to ceftriaxone 2
  • Do NOT use azithromycin in the United States due to widespread macrolide resistance and documented treatment failures 2, 4

Special Populations

Pregnant Women

All pregnant women with penicillin allergy MUST undergo desensitization followed by penicillin treatment—no exceptions. 1, 2, 5

  • Penicillin is the only therapy proven effective for preventing maternal transmission and treating fetal infection 2, 5
  • Some experts recommend a second dose of benzathine penicillin 2.4 million units IM one week after the initial dose for primary, secondary, or early latent syphilis in pregnancy 2
  • Screen all pregnant women at first prenatal visit, during third trimester, and at delivery 2
  • Jarisch-Herxheimer reaction during the second half of pregnancy may precipitate premature labor or fetal distress 2
  • Women should seek immediate medical attention if they notice contractions or changes in fetal movements after treatment 2
  • Tetracycline, doxycycline, erythromycin, azithromycin, and ceftriaxone are inadequate—erythromycin does not reliably cure fetal infection 2

HIV-Infected Patients

Use the same penicillin regimens as HIV-negative patients for all stages of syphilis. 1, 2, 5

  • HIV-infected patients may have atypical serologic responses but generally respond well to standard treatment 2
  • Closer follow-up is mandatory to detect treatment failure or disease progression 2, 5
  • Limited data suggest no benefit to multiple doses of benzathine penicillin for early syphilis in HIV-infected patients compared to a single dose 2, 6
  • Patients with penicillin allergy should undergo skin testing and desensitization, then be treated with penicillin 2

Pediatric Patients

For children with acquired primary or secondary syphilis: benzathine penicillin G 50,000 units/kg IM (up to adult dose of 2.4 million units) as a single dose. 1, 2

For late latent syphilis: benzathine penicillin G 50,000 units/kg IM for three doses at weekly intervals (total 150,000 units/kg up to 7.2 million units). 2

  • Children require CSF examination to exclude neurosyphilis before treatment 2
  • Incompletely developed renal function in newborns may delay penicillin elimination; appropriate dose reductions should be made 7, 8

Follow-Up and Monitoring

Repeat quantitative nontreponemal serologic tests (RPR or VDRL) at 6,12, and 24 months. 1, 2, 5

  • For primary/secondary syphilis, expect a fourfold decline in titer within 6 months 1, 2
  • For late syphilis, expect a fourfold decline within 12-24 months 1, 2
  • Perform CSF examination if titers increase fourfold, fail to decline appropriately, or neurological symptoms develop 1, 2
  • 15-25% of successfully treated patients remain "serofast" with persistent low titers (<1:8) that do not indicate treatment failure 2

Treatment Failure

Treatment failure is defined as persistent/recurring symptoms, sustained fourfold increase in titers, or failure of titers to decline fourfold within expected timeframes. 1, 2, 5

  • Re-evaluate for HIV infection and perform CSF examination 2
  • Re-treat with benzathine penicillin G 2.4 million units IM weekly for 3 weeks unless neurosyphilis is diagnosed 2

Management of Sex Partners

Persons exposed within 90 days preceding diagnosis of primary, secondary, or early latent syphilis should be treated presumptively, even if seronegative. 1, 2

  • Time periods for at-risk partners: 3 months plus duration of symptoms for primary syphilis, 6 months plus duration of symptoms for secondary syphilis, and 1 year for early latent syphilis 2
  • Long-term sex partners of patients with late syphilis should be evaluated clinically and serologically 1

Critical Pitfalls to Avoid

  • Never use oral penicillin preparations—they are completely ineffective for syphilis 2, 5
  • Do not use different serologic test methods (RPR vs VDRL) when monitoring response, as results cannot be directly compared 2, 5
  • Do not rely solely on treponemal test antibody titers to assess treatment response, as they correlate poorly with disease activity 2
  • Administer high-dose IV penicillin G (above 10 million units) slowly due to potential electrolyte imbalance from potassium content 7, 8
  • Warn patients about Jarisch-Herxheimer reaction, an acute febrile reaction with headache and myalgia that may occur within 24 hours of treatment 2, 5
  • All patients with syphilis should be tested for HIV infection 2

References

Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Syphilis: A Review.

JAMA, 2025

Research

Management of Adult Syphilis: Key Questions to Inform the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015

Guideline

Treatment for Stage 3 (Tertiary) Syphilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.